SCHEMBL6534728

SCHEMBL6534728

CNc1ccc(Cl)cc1S(=O)(=O)c1ccccc1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 2/20 0.44
FBP1 P09467 1/20 0.41
PTGES2 Q9H7Z7 1/20 0.40
CXCR2 P25025 2/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA4 P22748 1/20 0.40
CA6 P23280 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
TP53 P04637 1/20 0.39
TSHR P16473 4/20 0.38
NPC1 O15118 2/20 0.38
HPGD P15428 2/20 0.38
GRIK1 P39086 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6534886 0.82 HTR6 (0.62) HTR6CA1CA2CA4CA6
SCHEMBL6534765 0.80 HTR6 (0.65) HTR6KDM4EALDH1A1GLAGAA
SCHEMBL6535762 0.78 KMT2A (0.58) CA1CA2ALDH1A1GAAHTT
SCHEMBL6130586 0.76 PTGES2 (0.54) PTGES2CA1CA2CA4CA6
SCHEMBL6534700 0.74 TSHR (0.61) HTR6PTGES2KDM4EALDH1A1TP53
SCHEMBL3920031 0.74 CCR2 (0.50) KDM4EALDH1A1GLAGAATSHR
SCHEMBL6535672 0.73 HTR6 (0.44) HTR6PTGES2CXCR2CA1CA2
SCHEMBL38660050 0.73 CA1 (0.68) CA1CA2CA4CA6GAA
SCHEMBL2475835 0.73 CA1 (0.68) CA1CA2CA4CA6GAA
SCHEMBL6535042 0.71 TRPV4 (0.55) HTR6PTGES2ALDH1A1TP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1011652-A4 NOVEL DIARYLSULFONE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS UNIV THE SCIENCES IN PHILADELP (US) 2004-12-22 EP disclosed
US-6303630-B1 TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTION BYADMINISTERING TO A HUMAN DIARYLSULFONE COMPOUND UNIVERSITY OF THE SCIENCES IN PHILADELPHIA 2001-10-16 US disclosed
EP-1011652-A1 NOVEL DIARYLSULFONE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS University of the Sciences in Philadelphia (US) 2000-06-28 EP disclosed
US-6063790-A TREATMENT OF AIDS UNIVERSITY OF THE SCIENCES IN PHILADELPHIA (US) 2000-05-16 US disclosed
WO-1999006037-A1 NOVEL DIARYLSULFONE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS UNIVERSITY OF THE SCIENCES IN PHILADELPHIA (US) 1999-02-11 WO disclosed